The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBritish American Tobacco Regulatory News (BATS)

Share Price Information for British American Tobacco (BATS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,406.00
Bid: 2,404.00
Ask: 2,405.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.042%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 2,406.00
BATS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Share Buy-Back Programme

18 Mar 2024 07:00

RNS Number : 1404H
British American Tobacco PLC
18 March 2024
 

British American Tobacco p.l.c. (the "Company" or "BAT")

 

18 March 2024

SHARE BUY-BACK PROGRAMME

As previously announced on 13 March 2024, BAT today commences its programme to buyback BAT ordinary shares (the "Programme") using proceeds from sale of 436,851,457 ordinary shares in ITC Limited. The final net proceeds received by the BAT Group were £1.57bn and the Programme will buy back £1.60bn of BAT ordinary shares starting with £700mn in 2024 and with the remaining £900mn in 2025. The Programme will commence on 18 March 2024 and will end no later than 31 December 2025.

 

The purpose of the Programme is to reduce the issued share capital of the Company. The purchased shares will be cancelled. The Company has entered into an agreement with UBS AG London Branch ("UBS") to enable the purchase of Ordinary Shares for the initial stage of the Programme. UBS will purchase the Company's ordinary shares as principal and the Company will purchase such number of ordinary shares from UBS in accordance with the terms of the engagement.

 

The number of ordinary shares permitted to be purchased by the Company, pursuant to the authority granted by the shareholders at the annual general meeting of the Company on 19 April 2023 (the "2023 AGM"), is 223,590,721 ordinary shares. The Programme will be carried out on Recognised Investment Exchanges within the UK. For the avoidance of doubt, no repurchases will be made in respect of the Company's American Depositary Receipts.

 

Any purchases of ordinary shares by the Company in relation to this announcement will be conducted in accordance with the Company's general authority to repurchase shares granted by its shareholders at the Company's 2023 AGM and any further approvals to repurchase shares as may be granted by its shareholders from time to time, the Market Abuse Regulation 596/2014 and the Commission Delegated Regulation (2016/1052), in each case as such legislation forms part of domestic law by virtue of section 3 of the European Union (Withdrawal) Act 2018 (as amended) and Chapter 12 of the Financial Conduct Authority's Listing Rules and will be discontinued in the event the Company ceases to have the necessary general authority to repurchase ordinary shares.

 

Enquiries:

 

British American Tobacco Press Media Centre

+44 (0) 20 7845 2888 (24 hours) | @BATplc

 

Investor Relations

Victoria Buxton: +44 (0)20 7845 2012

Amy Chamberlain: +44 (0)20 7845 1124

Yetunde Ibe: +44 (0)20 7845 1095

John Harney: +44 (0)20 7845 1263

Jane Henderson: +44 (0)20 7845 1117

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFDLFFZXLLBBE
Date   Source Headline
7th Apr 202211:45 amRNSDirector/PDMR Shareholding
7th Apr 202211:45 amRNSDirector/PDMR Shareholding
6th Apr 20227:00 amRNSTransaction in Own Shares
5th Apr 20222:10 pmRNSDirector/PDMR Shareholding
5th Apr 20222:10 pmRNSDirector/PDMR Shareholding
5th Apr 20227:00 amRNSTransaction in Own Shares
4th Apr 20227:00 amRNSTransaction in Own Shares
1st Apr 20223:10 pmRNSDirector/PDMR Shareholding
1st Apr 20221:30 pmRNSDirector/PDMR Shareholding
1st Apr 202212:40 pmRNSTotal Voting Rights
1st Apr 20227:00 amRNSTransaction in Own Shares
31st Mar 20224:15 pmRNSDirector/PDMR Shareholding
31st Mar 20224:15 pmRNSDirector/PDMR Shareholding
31st Mar 20227:00 amRNSTransaction in Own Shares
30th Mar 20225:00 pmRNSDirector/PDMR Shareholding
30th Mar 20227:00 amRNSTransaction in Own Shares
29th Mar 20225:00 pmRNSDirector/PDMR Shareholding
29th Mar 20225:00 pmRNSDirector/PDMR Shareholding
29th Mar 20225:00 pmRNSDirector/PDMR Shareholding
29th Mar 20227:00 amRNSTransaction in Own Shares
28th Mar 20227:00 amRNSTransaction in Own Shares
25th Mar 20227:00 amRNSTransaction in Own Shares
24th Mar 20223:45 pmRNSClosing of Notes Offering
24th Mar 20227:00 amRNSTransaction in Own Shares
23rd Mar 20227:00 amRNSTransaction in Own Shares
22nd Mar 20227:00 amRNSTransaction in Own Shares
21st Mar 20227:05 amRNSTransaction in Own Shares
21st Mar 20227:00 amRNSBAT Announces Management Board Change
18th Mar 20227:13 amRNSTransaction in Own Shares
17th Mar 20225:15 pmRNSPublication of Prospectus
17th Mar 20228:00 amRNSNotice of AGM
17th Mar 20227:00 amRNSTransaction in Own Shares
16th Mar 20225:30 pmRNSClosing of Notes Offering
16th Mar 20227:00 amRNSTransaction in Own Shares
15th Mar 20224:30 pmRNSDirector/PDMR Shareholding
15th Mar 20227:00 amRNSTransaction in Own Shares
14th Mar 20227:00 amRNSBranch Register: Dividend Finalisation Information
14th Mar 20227:00 amRNSTransaction in Own Shares
11th Mar 20223:55 pmRNSRussia Business Update and Guidance Impact
11th Mar 20227:00 amRNSTransaction in Own Shares
10th Mar 20227:00 amRNSTransaction in Own Shares
9th Mar 20227:00 amRNSTransaction in Own Shares
8th Mar 20223:45 pmRNSAnnual Financial Report
8th Mar 20227:00 amRNSTransaction in Own Shares
7th Mar 20227:00 amRNSTransaction in Own Shares
4th Mar 20227:00 amRNSTransaction in Own Shares
3rd Mar 20222:00 pmRNSTransaction in Own Shares
3rd Mar 20221:00 pmRNSDirector/PDMR Shareholding
3rd Mar 20227:00 amRNSTransaction in Own Shares
2nd Mar 20227:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.